Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000538737 | SCV000626337 | uncertain significance | Fanconi anemia | 2021-08-24 | criteria provided, single submitter | clinical testing | This sequence change replaces proline with serine at codon 194 of the FANCG protein (p.Pro194Ser). The proline residue is moderately conserved and there is a moderate physicochemical difference between proline and serine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with FANCG-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001271372 | SCV001452483 | uncertain significance | Fanconi anemia complementation group G | 2020-04-13 | no assertion criteria provided | clinical testing |